PubRank

S Hino

Author PubWeight™ 96.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Gesamte Virusforsch 1974 3.24
2 DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol Cell Biol 1999 3.17
3 Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera. J Virol 1976 2.82
4 Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus. J Virol 1999 2.13
5 Amplification and detection of a single molecule of human immunodeficiency virus RNA. Virus Genes 1993 1.53
6 Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res 1985 1.53
7 Use of the curved linear-array echo endoscope to identify gastrorenal shunts in patients with gastric fundal varices. Endoscopy 2004 1.44
8 Population dynamics of phenol-degrading bacteria in activated sludge determined by gyrB-targeted quantitative PCR. Appl Environ Microbiol 1998 1.42
9 Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993 1.38
10 Immunological cross reactivity of Mason-Pfizer monkey virus with type C RNA viruses endogenous to primates. Nature 1976 1.37
11 Course and outcome of tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis 1999 1.35
12 Antigenic determinants of the 70,000 molecular weight glycoprotein of woolly monkey type C RNA virus. J Immunol 1975 1.35
13 Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein. Proc Natl Acad Sci U S A 1977 1.30
14 Differential expression of helper viral structural polypeptides in cells transformed by clonal isolates of woolly monkey sarcoma virus. J Virol 1975 1.22
15 Polyadenylate in the virion RNA of mouse hepatitis virus. J Biochem 1977 1.21
16 A novel beta-catenin-binding protein inhibits beta-catenin-dependent Tcf activation and axis formation. J Biol Chem 2000 1.20
17 Degree of immunity induced by killed vaccines to experimental salmonellosis in mice. Infect Immun 1972 1.15
18 Feedback inhibition of amidophosphoribosyltransferase regulates the rate of cell growth via purine nucleotide, DNA, and protein syntheses. J Biol Chem 2001 1.14
19 Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 1994 1.13
20 Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission. Jpn J Cancer Res 1985 1.12
21 Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Cancer Res 1998 1.09
22 Endogenous New World primate retrovirus: interspecies antigenic determinants shared with the major structural protein of type-D RNA viruses of Old World monkeys. Proc Natl Acad Sci U S A 1977 1.09
23 Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses. J Virol 1976 1.06
24 Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Gan 1984 1.04
25 Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer 2001 1.04
26 Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals. Clin Exp Immunol 1994 1.03
27 Effect of oxygen on heme and cytochrome content in some facultative bacteria. Enzyme 1973 1.02
28 Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase. J Biol Chem 1999 1.02
29 A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang 2010 1.02
30 Breaking the cycle of HTLV-I transmission via carrier mothers' milk. Lancet 1987 1.00
31 Three spliced mRNAs of TT virus transcribed from a plasmid containing the entire genome in COS1 cells. J Virol 2000 0.99
32 Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line. Lab Invest 2000 0.98
33 Clinical and radiological features in four adolescents with nutcracker syndrome. Pediatr Nephrol 2000 0.98
34 Milk-borne transmission of HTLV-I from carrier mothers to their children. Jpn J Cancer Res 1987 0.97
35 Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. Br J Cancer 1998 0.97
36 Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals. Jpn J Cancer Res 1992 0.95
37 Deleted HTLV-1 provirus in cord-blood samples of babies born to HTLV-1-carrier mothers. Int J Cancer 1998 0.94
38 Identification of a functionally important population in phenol-digesting activated sludge with antisera raised against isolated bacterial strains. Appl Environ Microbiol 1996 0.93
39 Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis. Int J Oncol 1998 0.92
40 Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res 1998 0.90
41 Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor. J Am Soc Nephrol 2001 0.88
42 Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 2000 0.88
43 RNA sequences and proteins specific to Friend strain of spleen focus-forming virus. Cold Spring Harb Symp Quant Biol 1980 0.87
44 Effects of bosentan on the skin lesions: an observational study from a single center in Japan. Rheumatol Int 2008 0.87
45 High frequency of postnatal transmission of TT virus in infancy. Arch Virol 2000 0.87
46 Occult hepatitis B infection in blood donors. Vox Sang 2008 0.86
47 Significance of postnatal mother-to-child transmission of human T-lymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma. J Med Virol 1986 0.86
48 Prevention of mother-to-child transmission of human T-lymphotropic virus type-I. Pediatrics 1990 0.86
49 Urinary transforming growth factor-beta in patients with glomerular diseases. Pediatr Nephrol 1997 0.86
50 Relation between the tumor-specific antigen and cytological characteristics in mouse mammary tumors. J Natl Cancer Inst 1970 0.85
51 Immunoprevention of x-ray-induced leukemias in the C57BL mouse. Proc Natl Acad Sci U S A 1977 0.85
52 Mother-to-child transmission of HTLV-1. Cancer Detect Prev 1991 0.84
53 Performance certification of gelatin particle agglutination assay for anti-HTLV-1 antibody: inconclusive positive results. Jpn J Cancer Res 1989 0.84
54 Intraparticulate localization of some peroxisomal enzymes related to fatty acid beta-oxidation. Eur J Biochem 1981 0.84
55 Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Japan. Vox Sang 2005 0.84
56 Heparin-binding EGF-like growth factor is expressed by mesangial cells and is involved in mesangial proliferation in glomerulonephritis. J Pathol 1999 0.84
57 Genetic recombination between mouse type C RNA viruses: a mechanism for endogenous viral gene amplification in mammalian cells. Proc Natl Acad Sci U S A 1978 0.83
58 Identification of two novel mutations in the CLCN5 gene in Japanese patients with familial idiopathic low molecular weight proteinuria (Japanese Dent's disease). Am J Kidney Dis 2001 0.83
59 HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers. Lancet 1994 0.83
60 Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability. Kidney Int 1999 0.82
61 Type-C virus structural antigens on the surface of the infected cell as determined by a humoral cytotoxicity assay. Int J Cancer 1978 0.82
62 Molecular cloning, expression, and chromosomal localization of a human tubulointerstitial nephritis antigen. Biochem Biophys Res Commun 2000 0.81
63 Portal hemodynamics in chronic portal-systemic encephalopathy. Angiographic study in seven cases. J Hepatol 1985 0.81
64 Intraoperative real-time genetic diagnosis for sentinel node navigation surgery. Int J Oral Maxillofac Surg 2004 0.81
65 Characteristics of a virus found in a Rous mouse cell line, SR-C3H-2127. Jpn J Exp Med 1972 0.81
66 Serum and monoclonal immunoglobulin E antibodies from NC/Nga mice with severe atopic-like dermatitis recognize an auto-antigen, histone H3. Clin Exp Allergy 2009 0.81
67 The target antigen of anti-tubular basement membrane antibody-mediated interstitial nephritis. Autoimmunity 1994 0.81
68 Milk-borne transmission of HTLV-I as a major route in the endemic cycle. Acta Paediatr Jpn 1989 0.81
69 Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line. Br J Cancer 2002 0.81
70 Triathlon competition induced a transient immunosuppressive change in the peripheral blood of athletes. J Sports Med Phys Fitness 1993 0.80
71 Detection of p16 promoter methylation in the serum of oral cancer patients. Int J Oral Maxillofac Surg 2005 0.80
72 Effect of time of day on adaptive response to a 4-week aerobic exercise program. J Sports Med Phys Fitness 1992 0.80
73 Chronic portal-systemic encephalopathy with normal portal vein pressure possibly due to noncirrhotic portal fibrosis. Dig Dis Sci 1984 0.80
74 In vivo enhancement of chemosensitivity of human salivary gland cancer cells by overexpression of TGF-beta stimulated clone-22. Oncol Rep 2000 0.80
75 Evolution in the hypervariable region of hepatitis C virus in infants after vertical transmission. Pediatr Res 2000 0.80
76 Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer. Int J Oncol 2001 0.80
77 Dependency of antibody titer on provirus load in human T lymphotropic virus type I carriers: an interpretation for the minor population of seronegative carriers. J Infect Dis 1995 0.79
78 Development of adult T-cell leukemia-lymphoma (ATL) in two anti-ATL-associated antigen-positive healthy adults. Gan 1982 0.79
79 Altered expression of a novel cellular gene as a consequence of integration of human T cell lymphotropic virus type 1. J Gen Virol 1994 0.79
80 Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients. Br J Cancer 1999 0.79
81 Exercise-induced changes in the expression of surface adhesion molecules on circulating granulocytes and lymphocytes subpopulations. Eur J Appl Physiol Occup Physiol 1995 0.79
82 Immobilization osteoporosis and active vitamin D: effect of active vitamin D analogs on the development of immobilization osteoporosis in rats. Calcif Tissue Int 1981 0.78
83 Balance between activated-STAT and MAP kinase regulates the growth of human bladder cell lines after treatment with epidermal growth factor. Int J Oncol 1999 0.78
84 Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines. Br J Cancer 2001 0.78
85 Transfusion-mediated spread of the human T-cell leukemia virus in chronic hemodialysis patients in a heavily endemic area, Nagasaki. Gan 1984 0.78
86 HTLV and the propagation of Christianity in Nagasaki. Lancet 1984 0.78
87 Proto-oncogene expression in human glomerular diseases. J Pathol 1996 0.77
88 Induction of peroxisomal enzymes in rat liver by the hypolipidemic agent LK-903. Biochem Pharmacol 1981 0.77
89 Transcriptional activation of cyclin-dependent kinase inhibitor, p21waf1 gene by treatment with a differentiation inducing agent, vesnarinone in a human salivary gland cancer cell line. J Exp Clin Cancer Res 2003 0.77
90 Physico-chemical properties of mouse hepatitis virus (MHV-2) grown on DBT cell culture. Microbiol Immunol 1978 0.76
91 Expression of tenascin in normal and diseased human kidneys. Nihon Jinzo Gakkai Shi 1996 0.76
92 Combined therapy in children and adolescents with IgA nephropathy. Nihon Jinzo Gakkai Shi 1994 0.76
93 Amplification of HTLV-1-related sequences among patients with neurological disorders in highly endemic Nagasaki: lack of evidence for association of HTLV-1 with multiple sclerosis. Jpn J Cancer Res 1990 0.76
94 Esophageal varices: correlation of left gastric venography and endoscopy in patients with portal hypertension. Radiology 1985 0.76
95 Isolation and characterization of the tubular basement membrane antigen associated with human tubulo-interstitial nephritis. Clin Exp Immunol 1992 0.75
96 ATL development after adult infection of HTLV-1? Jpn J Cancer Res 1989 0.75
97 [Clinical course and prognosis of peptic ulcer]. Saishin Igaku 1971 0.75
98 [A study on Shinpei Goto's "Mei-ka theory"] (Jpn). Nihon Ishigaku Zasshi 1988 0.75
99 Report of the Fifth International Conference on Human Retrovirology: Human T-cell Lymphotropic Virus. Jpn J Clin Oncol 1993 0.75
100 [Risk and prevention of infections in clinical laboratories. From the viewpoint of biohazard: importance and problems of biological safety cabinets]. Rinsho Byori 1988 0.75
101 Novel complications with HTLV-1-associated myelopathy/tropical spastic paraparesis: interstitial cystitis and persistent prostatitis. Jpn J Cancer Res 1992 0.75
102 Two independent outbreaks of measles in partially vaccinated junior high schools in Tottori, Japan. Arch Virol 1995 0.75
103 Studies on rous sarcoma virus in mice. II. Clonal analysis of cell populations of the SR-RSV-induced mouse ascites sarcoma (SR-C3H/HE ascites). Jpn J Exp Med 1967 0.75
104 [On the consistency of Shinpei Goto's theories of sanitary administration]. Nihon Ishigaku Zasshi 1988 0.75
105 [Present status of endoscopic therapy for esophageal varices--endoscopic variceal ligation (EVL)]. Nihon Geka Gakkai Zasshi 1996 0.75
106 Nazi's doctors thereafter. (Jpn) Igakushi Kenkyu 1975 0.75
107 Shift in the buoyant density of hepatitis C virus particles in infants infected by mother-to-infant transmission. Pediatr Int 1999 0.75
108 [Laboratory examinations in emergency cases: gastric juice test]. Naika 1965 0.75
109 Reevaluation of the biological certification test for the class II biological safety cabinets. Jpn J Exp Med 1984 0.75
110 [Cholecyto- and cholangiography as a routine examination--oral and intravenous administration]. Naika 1971 0.75
111 [Changes in temperature and humidity at different layers inside clothing during rest, exercise, and recovery]. Nihon Eiseigaku Zasshi 1989 0.75
112 [Review of this year's medical conferences--internal medicine]. Nihon Ishikai Zasshi 1965 0.75
113 [Recent trend in the study of digestive tract diseases]. Naika 1970 0.75
114 [Primary myelofibrosis associated with marked pulmonary fibrosis and hematopoiesis: report of a case (author's transl)]. Rinsho Ketsueki 1973 0.75
115 [Regulation of the synthesis of respiratory enzymes in bacteria]. Tanpakushitsu Kakusan Koso 1971 0.75
116 [Mother-to-child transmission of HTLV-I]. Nihon Rinsho 1986 0.75
117 A note on the modern medical history in Germany. (Jpn) Igakushi Kenkyu 1975 0.75
118 [Administration of digestive enzymes]. Naika 1967 0.75
119 Acupuncture anesthesia, waking suggestion and personality factors. Med J Osaka Univ 1978 0.75
120 [Interpretation of pathologic bone marrow smears (author's transl)]. Rinsho Byori 1978 0.75
121 [Present status of morphological examinations of the blood]. Rinsho Byori 1967 0.75
122 Immunohistochemical and immunoelectron microscopic study of an amylase-producing, CA19-9 positive ovarian mucinous cystadenocarcinoma. Gynecol Oncol 1988 0.75
123 [A case with cyclic thrombocytopenia: studies on platelet-kinetics and megakaryocyte]. Rinsho Ketsueki 1980 0.75
124 [Reversed C.P.C. (2). Analysis of anemia]. Rinsho Byori 1966 0.75
125 [Automated multiphasic health check-up]. Nihon Rinsho 1969 0.75
126 [The treatment of myelomatosis with melphalan (author's transl)]. Rinsho Ketsueki 1977 0.75
127 [Hemorrhage of the digestive tracts]. Nihon Rinsho 1970 0.75
128 [The lung disease of RA patients]. Rinsho Hoshasen 1985 0.75
129 [The validity of the estimated maximal oxygen intake by different indirect methods in middle-aged and elderly men]. Nihon Ronen Igakkai Zasshi 1984 0.75
130 Antibody to lymphadenopathy-associated virus in two Japanese hemophiliacs. Jpn J Exp Med 1985 0.75
131 Immunological analysis of structural polypeptides of woolly monkey-gibbon ape type C viruses. Expression of woolly monkey helper viral antigens in cells transformed by woolly monkey sarcoma virus. Bibl Haematol 1975 0.75
132 [Focal glomerular sclerosis in a sibling]. Nihon Jinzo Gakkai Shi 1993 0.75
133 [Differentiation of band-shaped and segmented nuclei of eosinophils]. Rinsho Ketsueki 1976 0.75
134 [Theory and practice of counting blood cells with hemocytometer (author's transl)]. Rinsho Ketsueki 1978 0.75
135 Hemodynamic and biochemical responses during exercise at the intensity equivalent to lactate threshold for middle-aged and elderly women. J Hum Ergol (Tokyo) 1987 0.75
136 [Non-surgical management of chronic constipation]. Geka Chiryo 1968 0.75
137 [Pancytopenia]. Rinsho Ketsueki 1977 0.75
138 [Clinical study on peptic ulcer treatment with sialogastrone]. Naika Hokan 1968 0.75
139 [Treatment of leukemia with Auer's bodies]. Nihon Rinsho 1968 0.75
140 Superoxide radical-induced degradation of polychlorobiphenyls and chlordanes at low temperature. Bull Environ Contam Toxicol 1991 0.75
141 On the final report of the C.C.M.C. (Jpn) Igakushi Kenkyu 1976 0.75
142 [Reorganization of public health services and regional problems in health care]. Hokenfu Zasshi 1987 0.75
143 [Leukemoid reactions]. Rinsho Byori 1972 0.75
144 Effect of mitotic inhibitors on C-type virion production. Jpn J Exp Med 1974 0.75
145 [Assay of blood coagulation factors in factor deficiency plasma]. Rinsho Ketsueki 1989 0.75
146 [A case of pseudomyxoma peritonei of appendiceal origin that metastasized to the spleen and complicated secondary systemic amyloidosis]. Nihon Shokakibyo Gakkai Zasshi 1997 0.75
147 Studies on rous sarcoma virus in mice. 3. Three lines of SR-RSV-induced mouse ascites sarcoma. Jpn J Exp Med 1969 0.75
148 A new unstable hemoglobin, Hb Yokohama beta 31 (B13)Leu substituting for Pro, causing hemolytic anemia. Hemoglobin 1981 0.75
149 Expression of the sarcoma genome in a Rous mouse tumor cell line, SR-C3H-2127. Gan 1971 0.75
150 [Mother-to-child transmission of human T-lymphotropic virus type-I]. Nihon Sanka Fujinka Gakkai Zasshi 1988 0.75
151 Sera of adult T-cell leukemia patients and carriers of human T-cell leukemia virus type I in Japan do not cross-react with antigens of lymphadenopathy virus. Jpn J Cancer Res 1985 0.75
152 Tissue-type plasminogen activator and its inhibitor in human glomerulonephritis. J Pathol 1992 0.75
153 [Vertigo caused by head and neck injuries]. Nihon Jibiinkoka Gakkai Kaiho 1970 0.75
154 Endogenous rat C-type virus in transplantable rat tumors. Jpn J Exp Med 1974 0.75
155 Gene Control of Resistance Vs. Sensitivity to Actidione in Saccharomyces. Genetics 1957 0.75
156 [Changes in temperature and humidity of various parts of the clothed body during rest, exercise, and recovery]. Nihon Eiseigaku Zasshi 1987 0.75
157 Collison 6-jet nebulizer: choice for the certification test of the class II biological safety cabinet. Jpn J Exp Med 1984 0.75
158 Variation in the mode of sugar transport among normal and tumor cells. Gan 1974 0.75
159 Board-to-Board Free-Space Optical Interconnections Passing through Boards for a Bookshelf-Assembled Terabit-Per-Second-Class ATM Switch. Appl Opt 1998 0.75
160 A cyclic gas distributor for multiple tissue culture chambers. Jpn J Exp Med 1974 0.75
161 [Historical notes on the Japanese Journal of Clinical Pathology (the Rinsho-Byori)]. Rinsho Byori 1984 0.75
162 Hydrogen-fluorine exchange in NaBH4-NaBF4. Phys Chem Chem Phys 2013 0.75
163 [Limitation in the care of leukemia patients - roles of the physician and the nurse]. Kango Gijutsu 1975 0.75
164 [Endosonography-guided celiac plexus neurolysis for cancer pain]. Nihon Rinsho 2001 0.75